The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1238
ISSUE1238
July 3, 2006
Insulin Detemir (Levemir), a New Long-Acting Insulin
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Insulin Detemir (Levemir), a New Long-Acting Insulin
July 3, 2006 (Issue: 1238)
Insulin detemir (Levemir - Novo Nordisk) is the second long-acting basal insulin analog to be marketed in the US for treatment of both type 1 and type 2 diabetes. Detemir differs from human insulin by the elimination of the amino acid threonine in...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.